SCHEMBL785137

SCHEMBL785137

Cc1cc(N2CCC(N(C)C(=O)c3ccc4c(c3)C(NC(=O)Nc3ccc(Cl)cc3C(F)(F)F)CC4)CC2)cc(C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.40
FPR2 P25090 3/20 0.38
TRPV1 Q8NER1 6/20 0.38
WDR5 P61964 1/20 0.38
PDK2 Q15119 1/20 0.38
FPR1 P21462 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
TLR9 Q9NR96 1/20 0.36
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
PROKR1 Q8TCW9 2/20 0.34
EPHX2 P34913 1/20 0.34
F2 P00734 1/20 0.34
PLAT P00750 1/20 0.34
KLKB1 P03952 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL785702 0.91 F10 (0.42) F10FPR2TRPV1WDR5FPR1
SCHEMBL785270 0.90 F10 (0.42) F10FPR2TRPV1WDR5FPR1
SCHEMBL785449 0.88 F10 (0.41) F10TRPV1WDR5PDK2CYP1A2
SCHEMBL785521 0.88 FPR2 (0.38) F10FPR2TRPV1WDR5PDK2
SCHEMBL785862 0.87 ALDH1A1 (0.42) F10TRPV1CYP1A2CYP2C19
SCHEMBL784981 0.87 TRPV1 (0.39) F10TRPV1TLR9TLR8TLR7
SCHEMBL785666 0.86 TRPV1 (0.44) F10FPR2TRPV1PDK2FPR1
SCHEMBL785814 0.86 TAS1R3 (0.44) F10TRPV1WDR5TLR9TLR8
SCHEMBL785571 0.86 F10 (0.41) F10FPR2TRPV1WDR5FPR1
SCHEMBL784884 0.85 TRPV1 (0.41) F10FPR2TRPV1RAB9AJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US claimed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US claimed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 F10 524/4885FPR2 426/4885TRPV1 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.